Medpace Holdings ($MEDP) Insider Trading & Smart Money Activity

Medpace Holdings, Inc. · Diagnostics & Research · Latest filing Oct 16, 2026

Medpace Holdings, Inc. ($MEDP) has 9 insider trades, 1 congress trade, 6 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($110.49M), net -$110.49M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$110.49M
Congress trades (12 mo)
1
13F moves on file
6
Analyst ratings on file
2

MEDP insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 1 / 0 2 / 2
Q3 2026 0 9 · $110.49M 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 1 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All MEDP insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F PineStone Asset Management Reduced -280 sh $923.79K —
13F Burney Co/ New +4.76K sh $2.97M Read
Analyst Mizuho Reiterates to Outperform PT $700 +2.0% —
Analyst UBS Raises to Neutral PT $673 -3.2% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 21.97K sh $13.74M -3.2% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 26.70K sh $16.58M -3.1% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 2.41K sh $1.49M +0.7% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 154 sh $95.57K -3.1% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 27.83K sh $17.29M -3.6% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 16.08K sh $10.11M +1.1% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 49.02K sh $30.79M -1.3% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 21.88K sh $13.64M -1.3% —
Insider Troendle August J.President & CEO Sell (Open-market sale) 10.88K sh $6.75M +0.9% —
Congress David Taylor Purchase $1,001 - $15,000 +4.2%+12.6% Read
13F Fundsmith Reduced -19.90K sh $33.19M +4.2%+12.6% Read
13F Mawer Investment Management Added +38.80K sh $236.25M -0.7%+6.4% —
13F Pinestone Asset Management Reduced -22.06K sh $1.40M +1.5%+8.1% —
13F Wasatch Advisors Added +125.62K sh $409.87M -20.4%-16.5% —

1W / 1M / 6M = how MEDP moved from the trade or filing date.

Insider trading in MEDP: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Troendle August J. President & CEO 9 -$110.49M Sep 30, 2026

Members of Congress trading MEDP

Institutions moving MEDP (13F)

Analyst ratings on MEDP

DateFirmActionRatingPrice target1W1M6MStory
Mizuho Reiterates Outperform $665 → $700 +2.0% —
UBS Raises Neutral $405 → $673 -3.2% —

Frequently asked questions

Are MEDP insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 9 open-market sales worth $110.49M, a net -$110.49M.

What is the latest insider trade in MEDP?

Troendle August J., President & CEO filed a sell (open-market sale) of 21.97K sh worth $13.74M on Sep 30, 2026.

Which members of Congress traded MEDP?

1 disclosed trade by David Taylor. The latest was on May 15, 2026.

Which institutions changed their MEDP positions?

Recent 13F filers moving the stock include Pinestone Asset Management, Burney Co/, Fundsmith, Mawer Investment Management and Wasatch Advisors.

Other diagnostics & research stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text